+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy



Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy



Journal of Clinical Biochemistry and Nutrition 51(2): 114-116



The aim of this study was to compare the efficacy and tolerability of the first-line Helicobacter pylori (H. pylori) eradication regimen composed of proton pump inhibitor, clarithromycin, and amoxicillin, with those of a regimen composed of proton pump inhibitor, metronidazole, and amoxicillin. Data of patients, who were administered the first-line H. pylori eradication regimen at Tokyo Medical Center between 2008 and 2011, were reviewed. All patients had H. pylori gastritis without peptic ulcer disease. The 7-day triple regimen composed of lansoprazole, clarithromycin, and amoxicillin was administered to 55 patients, and that composed of omeprazole, metronidazole, and amoxicillin was administered to 55 patients. Intention-to-treat and per-protocol eradication rates were 74.5 and 80.4%, respectively, for the regimen of lansoprazole, clarithromycin, and amoxicillin, whereas the corresponding rates were 96.4 and 100%, respectively, for the regimen of omeprazole, metronidazole, and amoxicillin. In conclusion, first-line H. pylori eradication therapy composed of omeprazole, metronidazole, and amoxicillin was significantly more effective than that composed of lansoprazole, clarithromycin, and amoxicillin, without differences in tolerability.

(PDF emailed within 0-6 h: $19.90)

Accession: 055260278

Download citation: RISBibTeXText

PMID: 22962528

DOI: 10.3164/jcbn.D-11-00029R1


Related references

Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children. Digestive Diseases and Sciences 54(8): 1720-1724, 2008

Metronidazole is more effective than amoxicillin in combination with clarithromycin and proton pump inhibitor for Helicobacter pylori eradication in Japan. Gastroenterology 122(4 Suppl 1): A 587-A 588, 2002

Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin. Journal of Clinical Biochemistry and Nutrition 47(1): 53-58, 2010

Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection. Helicobacter 11(5): 436-440, 2006

Triple therapy with proton pump inhibitor - amoxicillin and clarithromycin for Helicobacter pylori eradication. Gastroenterology 108(4 SUPPL ): A143, 1995

Triple therapy using proton pump inhibitor Amoxicillin and clarithromycin for Helicobacter pylori eradication. Gut 37(SUPPL 1): A91, 1995

Seven-day versus 10- to 14-day therapies with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Helicobacter pylori infection A metaanalysis. Gastroenterology 118(4 Suppl 2 Part 1): AGA A494, 2000

Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. Alimentary Pharmacology and Therapeutics 17(2): 259-264, 2003

Acid-related diseases. What is the current rescue treatment of choice for Helicobacter pylori: quadruple therapy (proton pump inhibitor, bismuth, tetracycline and metronidazole) or triple therapy with proton pump inhibitor, amoxicillin and levofloxacin?. Gastroenterologia Y Hepatologia 31(6): 400-401, 2008

Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy: Factors that influence Helicobacter pylori eradication success. Revista Espanola de Enfermedades Digestivas 95(3): 206-209, Marzo, 2003

Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy. Helicobacter 18(4): 270-273, 2013

Effect of amoxicillin, clarithromycin, and rabeprazole, a new proton pump inhibitor, in eradication therapy for relapsing peptic ulcer diseases with Helicobacter pylori infection. Journal of Clinical Gastroenterology 31(4): 338-339, 2000

Proton pump inhibitor, clarithromycin and amoxicillin or nitroimidazole A meta-analysis of its efficacy on Helicobacter pylori eradication. Gut 47(Supplement 1): A104, 2000

One week clarithromycin 500 mg bid is better than 250 mg bid for eradicating Helicobacter pylori infection when combined with proton pump inhibitor and metronidazole or amoxicillin A meta-analysis. Gastroenterology 112(4 SUPPL ): A153, 1997

High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin. Hepato-Gastroenterology 50(54): 2274-2278, 2003